2-N-[[4-(6-chloroisoquinolin-1-yl)oxyphenyl]methyl]-3-methyl-5-N-(oxetan-3-yl)benzimidazole-2,5-diamine
C27H24ClN5O2 — CID 118858498
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-N-[[4-(6-chloroisoquinolin-1-yl)oxyphenyl]methyl]-3-methyl-5-N-(oxetan-3-yl)benzimidazole-2,5-diamine
2-N-[[4-(6-chloroisoquinolin-1-yl)oxyphenyl]methyl]-3-methyl-5-N-(oxetan-3-yl)benzimidazole-2,5-diamine (PubChem CID 118858498) has the molecular formula C27H24ClN5O2 and a molecular weight of 485.98 g/mol. Its IUPAC name is 2-N-[[4-(6-chloroisoquinolin-1-yl)oxyphenyl]methyl]-3-methyl-5-N-(oxetan-3-yl)benzimidazole-2,5-diamine.
Molecular Properties
| Compound Name | 2-N-[[4-(6-chloroisoquinolin-1-yl)oxyphenyl]methyl]-3-methyl-5-N-(oxetan-3-yl)benzimidazole-2,5-diamine |
|---|---|
| PubChem CID | 118858498 |
| Molecular Formula | C27H24ClN5O2 |
| Molecular Weight | 485.98 g/mol |
| Exact Mass | 485.16 |
| IUPAC Name | 2-N-[[4-(6-chloroisoquinolin-1-yl)oxyphenyl]methyl]-3-methyl-5-N-(oxetan-3-yl)benzimidazole-2,5-diamine |
| SMILES | Cn1c(NCc2ccc(Oc3nccc4cc(Cl)ccc34)cc2)nc2ccc(NC3COC3)cc21 |
| InChI | InChI=1S/C27H24ClN5O2/c1-33-25-13-20(31-21-15-34-16-21)5-9-24(25)32-27(33)30-14-17-2-6-22(7-3-17)35-26-23-8-4-19(28)12-18(23)10-11-29-26/h2-13,21,31H,14-16H2,1H3,(H,30,32) |
| InChIKey | BJEUGSARVSYHHT-UHFFFAOYSA-N |
| XLogP | 5.99 |
| TPSA | 73.23 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 35 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 485.98 |
| LogP ≤ 5 | 5.99 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 118858498 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.